Cite
HARVARD Citation
Card, T. et al. (n.d.). P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data. Journal of Crohn's and colitis. pp. S483-S484. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Card, T. et al. (n.d.). P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data. Journal of Crohn's and colitis. pp. S483-S484. [Online].